Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Moleculin Biotech has completed patient dosing in Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine for relapsed or refractory acute myeloid leukemia (R/R AML). The company remains on track to report comprehensive data from the 90-patient Part A population in the first quarter of 2027, which will inform dose selection for Part B of the trial.
SouthState Bank Corp reported net income of $223.8 million for the third quarter of 2026, a decrease from $246.6 million in the prior year period. Total assets grew to $70.4 billion, driven by a significant increase in non-acquired loans, while the company maintained a strong capital position despite an increase in accumulated other comprehensive loss.
Arbor Realty Trust reported a GAAP net loss of $85.4 million for the third quarter of 2026, significantly down from net income of $38.5 million in the prior year. Due to the challenging market environment, the company has suspended its quarterly cash dividend on common stock to preserve capital and maintain financial flexibility.
Mastech Digital reported third quarter 2026 financial results, highlighting its second consecutive quarter of sequential revenue growth driven by momentum in its Data & AI segment. While total revenues declined 13.4% year-over-year to $42.0 million, the Data & AI segment saw a 4.7% sequential increase and a 29% increase in bookings compared to the prior year period.
Term
Q3 2026
“This quarter marks a significant milestone, as we launched the new Mastech brand and our vision of the Knowledge-first Enterprise. We believe enterprises need to codify the knowledge held by their people, customers, and clients to transform with AI. We are seeing enterprises move past AI experimentation. They now want to put their own data and knowledge to work in production, and that is driving our focus on building trusted data foundations, Applied AI solutions, and the specialized talent that our clients need to deliver AI outcomes at scale.”
Nirav Patel, Mastech's President and Chief Executive Officer
BrightSpring Health Services reported total current assets of $2.77 billion as of September 30, 2026, a slight decrease from $2.89 billion at year-end 2025, primarily due to the disposition of assets held for sale. The company maintained a significant cash position of $717.8 million and reported 198,984,612 shares of common stock outstanding as of October 27, 2026.
Red River Bancshares reported record-high quarterly net income of $12.6 million and EPS of $1.90 for the third quarter of 2026. The results were driven by a 3.2% increase in net interest income and growth in both loans and deposits, which reached $2.32 billion and $2.96 billion respectively. The company also completed its New Orleans banking center relocation and continued its organic expansion in the Acadiana market.
Nelnet, Inc.'s wholly-owned subsidiary, Nelnet Bank, filed its quarterly Consolidated Reports of Condition and Income (Call Report) with the FDIC for the period ended September 30, 2026. The filing serves as a regulatory disclosure update for the bank's financial condition and operations, which are now publicly available on the FDIC website.
Verra Mobility reported a significant increase in cash and cash equivalents to $137.0 million as of September 30, 2026, compared to $65.3 million at year-end 2025. The company is navigating material customer concentration risks, including the termination of a contract with a major Commercial Services customer effective January 2027 and less favorable renewal terms with other key clients.
IRADIMED reported record Q3 2026 revenue of $24.2 million, a 14% year-over-year increase driven by the launch of its new 3870 MR IV pump. The company also declared a quarterly cash dividend of $0.20 per share and updated its full-year 2026 revenue guidance to a range of $91.6 million to $93.1 million.
Term
Q3 2026
“We are pleased to report record revenue of $24.2 million for the third quarter, driven by the continued successful launch of our new 3870 MR IV pump. As our manufacturing team gains experience with the new platform while at the same time greatly ramping up production, we began realizing the efficiencies we anticipated with gross margin improving sequentially as expected.”
Roger Susi, President and Chief Executive Officer of Iradimed
“For the fourth quarter of 2026, we expect revenue of $25.0 million to $26.5 million, attaining a $100.0 million revenue run rate while generating GAAP diluted earnings per share of $0.53 to $0.57 and non-GAAP diluted earnings per share of $0.57 to $0.61.”
Roger Susi, President and Chief Executive Officer of Iradimed
Verra Mobility reported third quarter 2026 financial results with total revenue of $258.9 million and net income of $40.4 million. The company reaffirmed its full-year 2026 guidance and noted record bookings in its Government Solutions segment, despite a 14% revenue decline in Commercial Services. Due to pending leadership transitions, the company did not hold a concurrent earnings conference call.
OpenWorld, Inc. entered into a securities purchase agreement for a $3.5 million registered direct offering with a single institutional investor. The company is selling 2,517,985 shares of common stock at a combined price of $1.39 per share, including accompanying Series A and Series B warrants. Proceeds are intended for real-world asset growth initiatives and general corporate purposes.
Hilton Grand Vacations Announces $200M Stock Buyback
Hilton Grand Vacations Inc. entered into an accelerated share repurchase (ASR) agreement with Deutsche Bank to repurchase $200 million of its common stock. The company will receive an initial delivery of approximately 4.48 million shares on October 30, 2026, with final settlement expected by December 31, 2026. This transaction is part of the company's previously authorized share repurchase program.
Starwood Credit Real Estate Income Trust declared monthly cash distributions for October 2026 across its Class S, Class I, and Class E common shares. All classes will receive a gross distribution of $0.1300 per share, payable on or about November 4, 2026, to shareholders of record as of October 30, 2026.
Colgate-Palmolive reported net sales of $5,369 million for the quarter ended September 30, 2026, a 4.6% increase over the prior year. While net income attributable to the company rose slightly to $751 million for the quarter, nine-month year-to-date net income decreased from $2,169 million to $2,090 million, primarily due to higher selling, general, and administrative expenses and other net expenses.
TerraVolt Holdings entered into option agreements to acquire 1,077 acres in Cassia County, Idaho, for the development of a 240 MW gas-powered digital infrastructure campus. The company paid a $150,000 option fee for the site, which is designed to operate behind-the-meter to avoid grid interconnection delays. The total purchase price for the land is approximately $32.31 million ($30,000 per acre), payable in a mix of cash and a convertible secured promissory note.
Oxford Square Capital Corp. declared monthly cash distributions of $0.015 per share for January, February, and March 2027. The company also reported third-quarter 2026 results, including net investment income of $4.9 million and a net asset value of $1.21 per share.
Pluri Inc. entered into a partnership agreement with ZEO ScientifiX to grant ZEO an exclusive license to manufacture and commercialize Pluri's regenerative medicine portfolio in the United States. In exchange, Pluri will receive a 50% equity stake in ZEO and the right to designate four out of seven board members, while ZEO will receive approximately 9% of Pluri's outstanding common shares.
Zeo ScientifiX entered into a definitive strategic agreement with Pluri Inc. to expand U.S. manufacturing and commercialization of regenerative medicine products. As part of the license-for-equity transaction, Pluri will grant ZEO an exclusive license to its proprietary 3D cell expansion platform in exchange for a 41% equity stake in ZEO and a share swap involving 4% of each company's outstanding stock.
Neo-Concept International Group Holdings reported a net loss of HKD 9.1 million for the first half of 2026, compared to a net income of HKD 2.0 million in the prior year period, driven by a decline in revenue and increased staff and inventory impairment costs. Total assets increased significantly to HKD 166.1 million, largely due to a substantial increase in prepayments to related parties and proceeds from a share placement.
Oppenheimer Holdings reported third quarter 2026 revenue of $382.0 million and net income of $5.5 million, down from $21.7 million in the prior year. Results were significantly impacted by a $21.0 million pre-tax expense related to a stock-price-linked employee incentive program following a $12.42 per share increase in the company's stock price during the quarter.
Term
Q3 2026
“The Firm's operating results for the third quarter reflected generally constructive market conditions, although earnings were disappointing due to lower retail trading activity, reduced investment banking volumes and higher expense associated with the increased value of stock appreciation rights resulting from the change in the Company's stock price during the quarter.”
OmniAb, Inc. reported total revenue of $31.8 million for the nine months ended September 30, 2026, a significant increase from $10.3 million in the prior year period, primarily driven by license and milestone revenue. Despite the revenue growth, the company recorded a net loss of $29.3 million for the first nine months of 2026, though this was an improvement over the $50.6 million net loss reported for the same period in 2025.
Oppenheimer Holdings Inc. reported total revenue of $1.28 billion for the first nine months of 2026, up from $1.17 billion in 2025, driven by growth in advisory fees and investment banking. However, net income for the period fell significantly to $12.2 million from $74.0 million, primarily due to a $70 million expense related to a 'cash sweep' program litigation settlement.
Organon & M&A Deal with Sun Pharmaceutical Industries Limited
Organon & Co. provided a status update on its pending merger with Sun Pharmaceutical Industries Limited, noting that it has suspended customary earnings calls and press releases due to the transaction. The company furnished supplemental non-GAAP financial metrics for the third quarter of 2026 in lieu of a formal earnings release while the merger remains active.
Cboe Global Markets, Inc. filed its 10-Q for the period ending September 30, 2026, reporting 104,330,235 shares of common stock outstanding as of October 23, 2026. The filing includes unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2026, and identifies the company as a large accelerated filer.
Mammoth Energy Services $58M Debt Financing with Bank7
Mammoth Energy Services' aviation subsidiaries entered into a $58 million senior secured term loan facility with Bank7 to finance the acquisition of additional aircraft. The facility consists of a $25 million Term Loan A and a $33 million Term Loan B, maturing on October 26, 2030, with interest at a variable rate of at least 6.25%.
General Dynamics reported strong third-quarter 2026 results with revenue increasing 12.9% to $14.6 billion and diluted EPS rising 15.7% to $4.49. The company saw exceptional order activity totaling $98.8 billion, driven by major submarine contracts in the Marine Systems segment, resulting in a record backlog of $220.3 billion.
Term
Q3 2026
“Our business had exceptional third quarter results, with revenue growth across all four segments, robust bookings and solid operational performance. With the consistent growth in our backlog and our significant investment in our businesses over the last decade, we are poised to drive continued performance in the years to come.”
Phebe Novakovic, chairman and chief executive officer
Aurinia Pharmaceuticals reported a significant increase in net income to $103.5 million for the nine months ended September 30, 2026, compared to $76.4 million in the prior year period, driven by a 19% growth in total revenue. The company maintained a strong liquidity position with $486.9 million in cash and short-term investments while continuing its share repurchase program.
Piper Sandler Companies reported third quarter 2026 net revenues of $443 million and GAAP net income of $55 million, or $0.78 per diluted share. The company also announced a new $200 million share repurchase authorization and declared a quarterly dividend of $0.20 per share.
Term
Q3 2026
“We delivered solid results for the third quarter, supported by 18% year-over-year growth in advisory services revenues and increased client activity in fixed income. As we build on our record year-to-date revenues, we remain focused on supporting our clients across dynamic markets, finishing the year strong and continuing to return capital to our shareholders.”
Chad Abraham, chairman and chief executive officer
Organon & Co. reported a slight decrease in quarterly revenues to $1.57 billion for Q3 2026, though net income rose to $164 million compared to $160 million in the prior year period. The company significantly strengthened its cash position to $1.46 billion, bolstered by $433 million in proceeds from the sale of Jada.
Aurinia Pharmaceuticals reported Q3 2026 financial results with total revenue of $83.7 million, a 14% increase year-over-year, driven by $79.4 million in net product sales of LUPKYNIS. The company reported net income of $31.7 million and increased its full-year 2026 total revenue guidance to a range of $325 million to $330 million.